BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21965750)

  • 1. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients.
    Tutino V; Notarnicola M; Guerra V; Lorusso D; Caruso MG
    Anticancer Res; 2011 Oct; 31(10):3381-3. PubMed ID: 21965750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin and its receptors in obese patients with colorectal cancer.
    Stachowicz M; Mazurek U; Nowakowska-Zajdel E; Niedworok E; Fatyga E; Muc-Wierzgon M
    J Biol Regul Homeost Agents; 2010; 24(3):287-95. PubMed ID: 20846476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis.
    Endo H; Hosono K; Uchiyama T; Sakai E; Sugiyama M; Takahashi H; Nakajima N; Wada K; Takeda K; Nakagama H; Nakajima A
    Gut; 2011 Oct; 60(10):1363-71. PubMed ID: 21406387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
    Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
    Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study.
    Bolukbas FF; Kilic H; Bolukbas C; Gumus M; Horoz M; Turhal NS; Kavakli B
    BMC Cancer; 2004 Jun; 4():29. PubMed ID: 15217519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.
    Stattin P; Palmqvist R; Söderberg S; Biessy C; Ardnor B; Hallmans G; Kaaks R; Olsson T
    Oncol Rep; 2003; 10(6):2015-21. PubMed ID: 14534736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer.
    Ferroni P; Palmirotta R; Spila A; Martini F; Raparelli V; Fossile E; Mariotti S; Del Monte G; Buonomo O; Roselli M; Guadagni F
    Anticancer Res; 2007; 27(1B):483-9. PubMed ID: 17348431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the leptin receptor in the immune response in intestinal cancer.
    Aloulou N; Bastuji-Garin S; Le Gouvello S; Abolhassani M; Chaumette MT; Charachon A; Leroy K; Sobhani I
    Cancer Res; 2008 Nov; 68(22):9413-22. PubMed ID: 19010916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
    Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
    Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
    Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum soluble VEGFR-1 and Tie-2 receptors in colorectal cancer patients following surgical resections.
    Chin KF; Greenman J; Reusch P; Gardiner E; Marme D; Monson J
    Anticancer Res; 2004; 24(4):2353-7. PubMed ID: 15330184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin receptor is involved in STAT3 activation in human colorectal adenoma.
    Uchiyama T; Takahashi H; Sugiyama M; Sakai E; Endo H; Hosono K; Yoneda K; Yoneda M; Inamori M; Nagashima Y; Inayama Y; Wada K; Nakajima A
    Cancer Sci; 2011 Feb; 102(2):367-72. PubMed ID: 21166956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin, leptin soluble receptor and coronary atherosclerosis.
    Hoefle G; Saely CH; Risch L; Rein P; Koch L; Schmid F; Aczél S; Marte T; Langer P; Drexel H
    Eur J Clin Invest; 2007 Aug; 37(8):629-36. PubMed ID: 17635573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulating galectins as colorectal cancer markers.
    Watanabe M; Takemasa I; Kaneko N; Yokoyama Y; Matsuo E; Iwasa S; Mori M; Matsuura N; Monden M; Nishimura O
    Oncol Rep; 2011 May; 25(5):1217-26. PubMed ID: 21369702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.